Plasma plasminogen activator inhibitor-1 is associated with end-stage proliferative diabetic retinopathy in the Northern Chinese Han population

Experimental Diabetes Research

Volumn 2012, Issue , 2012, Pages

  Zhong, Ze Long ^a,b   Chen, Song ^a,b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN EYE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; BIOLOGICAL MARKER; SERPINE1 PROTEIN, HUMAN;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; AGED; ASIAN; BLOOD; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CHINA; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEDIGREE; RISK; STATISTICAL MODEL; TIME; UPREGULATION;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PEDIGREE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RISK FACTORS; SMOKING; TIME FACTORS; UP-REGULATION;

MLCS; MLOWN;

EID: 84871463416     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2012/350852     Document Type: Article

References (40)

1. Sieu N., Katon W., Lin E. H. B., Russo J., Ludman E., Ciechanowski P., Depression and incident diabetic retinopathy: a prospective cohort study. General Hospital Psychiatry 2011 33 5 429 435 2-s2.0-79960162302 10.1016/j.genhosppsych.2011.05.021
2. Stevens J., Truesdale K. P., Katz E. G., Cai J., Impact of body mass index on incident hypertension and diabetes in Chinese Asians, American Whites, and American Blacks: The People's Republic of China study and the atherosclerosis risk in communities study. American Journal of Epidemiology 2008 167 11 1365 1374 2-s2.0-44449115716 10.1093/aje/kwn060 (Pubitemid 351770554)
3. Wong T. Y. H., Poon P., Szeto C. C., Chan J. C. N., Li P. K. T., Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients. Kidney International 2000 57 2 632 638 2-s2.0-0033935856 10.1046/j.1523-1755.2000.00884.x (Pubitemid 30430656)
4. Li B., Liu S., Miao L., Cai L., Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy. Experimental Diabetes Research 2012 2012 7 216512
5. Gumieniczek A., Owczarek B., Pawlikowska B., Oxidative/ nitrosative stress and protein damages in aqueous humor of hyperglycemic rabbits: effects of two oral antidiabetics, pioglitazone and repaglinide. Experimental Diabetes Research 2012 2012 653678
6. Chun M. Y., Hwang H. S., Cho H. Y., Chun H. J., Woo J. T., Lee K. W., Nam M. S., Baik S. H., Kim Y. S., Park Y., Association of vascular endothelial growth factor polymorphisms with nonproliferative and proliferative diabetic retinopathy. Journal of Clinical Endocrinology and Metabolism 2010 95 7 3547 3551 2-s2.0-77954927699 10.1210/jc.2009-2719
7. Galetović D., Karlica D., Bućan K., Znaor L., The role of clinical and metabolic factors in the genesis and development of diabetic retinopathy. Acta Medica Croatica 2008 62 1 23 27 2-s2.0-40649098594 (Pubitemid 351373633)
8. Esteves J., Laranjeira A. F., Roggia M. F., Dalpizol M., Scocco C., Kramer C. K., Azevedo M. J., Canani L. H., Diabetic retinopathy risk factors. Arquivos Brasileiros de Endocrinologia e Metabologia 2008 52 3 431 441 2-s2.0-44949243230 10.1590/S0004-27302008000300003
9. Zhong Z. L., Han M., Chen S., Risk factors associated with retinal neovascularization of diabetic retinopathy in type 2 diabetes mellitus. International Journal of Ophthalmology 2011 4 2 182 185
10. Van Leiden H. A., Dekker J. M., Moll A. C., Nijpels G., Heine R. J., Bouter L. M., Stehouwer C. D. A., Polak B. C. P., Risk factors for incident retinopathy in a diabetic and nondiabetic population: The Hoorn study. Archives of Ophthalmology 2003 121 2 245 251 2-s2.0-0037314210 (Pubitemid 36184039)
11. Rodrigues T. C., Pecis M., Azevedo M. J., Gross J. L., Blood pressure homeostasis and microvascular complications in diabetic patients. Arquivos Brasileiros de Endocrinologia e Metabologia 2005 49 6 882 890 2-s2.0-33747595427
12. Cai X. L., Wang F., Ji L. N., Risk factors of diabetic retinopathy in type 2 diabetic patients. Chinese Medical Journal 2006 119 10 822 826 2-s2.0-33744469569 (Pubitemid 43796811)
13. Leitão C. B., Canani L. H., Silveiro S. P., Gross J. L., Ambulatory blood pressure monitoring and type 2 diabetes mellitus. Arquivos Brasileiros de Cardiologia 2007 89 5 315 354 2-s2.0-52049125099
14. Xie X. W., Xu L., Wang Y. X., Jonas J. B., Prevalence and associated factors of diabetic retinopathy. The Beijing Eye Study 2006. Graefe's Archive for Clinical and Experimental Ophthalmology 2008 246 11 1519 1526 2-s2.0-54049124450 10.1007/s00417-008-0884-6
15. Li J., Hu Y. H., Susceptibility genes for diabetic retinopathy. International Ophthalmology 2009 2 1 1 6
16. Xie X. W., Xu L., Wang Y. X., Jonas J. B., Prevalence and associated factors of diabetic retinopathy. The Beijing Eye Study 2006. Graefe's Archive for Clinical and Experimental Ophthalmology 2008 246 11 1519 1526 2-s2.0-54049124450 10.1007/s00417-008-0884-6
17. Yang K. J., Sun C. C., Ku W. C., Chuang L. H., Ching Ng S., Chou K. M., Kuo S. F., Yeung L., Axial length and proliferative diabetic retinopathy. Optometry & Vision Science 2012 89 465 470
18. Follo M., Ginsburg D., Structure and expression of the human gene encoding plasminogen activator inhibitor, PAI-1. Gene 1989 84 2 447 453 2-s2.0-0024793585 10.1016/0378-1119(89)90519-2 (Pubitemid 20043791)
19. Yan S. F., Pinsky D. J., Mackman N., Stern D. M., Egr-1: is it always immediate and early? Journal of Clinical Investigation 2000 105 5 553 554 2-s2.0-0034060814 (Pubitemid 30146497)
20. Liao H., Hyman M. C., Lawrence D. A., Pinsky D. J., Molecular regulation of the PAI-1 gene by hypoxia: contributions of Egr-1, HIF-1 α and C/EBP α FASEB Journal 2007 21 3 935 949 2-s2.0-33847373884 10.1096/fj.06-6285com (Pubitemid 46348266)
21. Kahn R., Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997 20 7 1183 1197 2-s2.0-1842334456 (Pubitemid 27274286)
22. Klein R., Knudtson M. D., Lee K. E., Gangnon R., Klein B. E. K., The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXII. The twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 2008 115 11 1859 1868 2-s2.0-54949133248 10.1016/j.ophtha.2008.08.023
23. Davis M. D., Fisher M. R., Gangnon R. E., Barton F., Aiello L. M., Chew E. Y., Ferris F. L., Knatterud G. L., Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: early treatment diabetic retinopathy study report 18. Investigative Ophthalmology and Visual Science 1998 39 2 233 252 2-s2.0-0031917205 (Pubitemid 28093859)
24. Koivisto V. A., Stevens L. K., Mattock M., Ebeling P., Muggeo M., Stephenson J., Idzior-Walus B., Cardiovascular disease and its risk factors in IDDM in Europe. Diabetes Care 1996 19 7 689 697 2-s2.0-0029951345 (Pubitemid 26249718)
25. Zhang L., Curhan G. C., Hu F. B., Rimm E. B., Forman J. P., Association between passive and active smoking and incident type 2 diabetes in women. Diabetes Care 2011 34 4 892 897 2-s2.0-79956202898 10.2337/dc10-2087
26. Kruszynska Y. T., Yu J. G., Olefsky J. M., Sobel B. E., Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects. Diabetes 2000 49 4 633 639 2-s2.0-0034126428 (Pubitemid 30183753)
27. Ugajin M., Yamaki K., Iwamura N., Yagi T., Asano T., Blood urea nitrogen to serum albumin ratio independently predicts mortality and severity of community- acquired pneumonia. International Journal of General Medicine 2012 5 583 589
28. Závada J., Hoste E., Cartin-Ceba R., Calzavacca P., Gajic O., Clermont G., Bellomo R., Kellum J. A., A comparison of three methods to estimate baseline creatinine for RIFLE classification. Nephrology Dialysis Transplantation 2010 25 12 3911 3918 2-s2.0-78649499055 10.1093/ndt/gfp766
29. Ko G. T. C., Wai H. P. S., Tang J. S. F., Effects of age on plasma glucose levels in non-diabetic Hong Kong Chinese. Croatian Medical Journal 2006 47 5 709 713 2-s2.0-33750629364 (Pubitemid 44690988)
30. Wang S., Xu L., Jonas J. B., Wang Y. X., You Q. S., Yang H., Dyslipidemia and eye diseases in the adult Chinese population: The Beijing Eye Study. PLoS One 2012 7 3, article e26871
31. Ezzidi I., Mtiraoui N., Chaieb M., Kacem M., Mahjoub T., Almawi W. Y., Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients. Diabetes and Metabolism 2009 35 3 214 219 2-s2.0-67349163252 10.1016/j.diabet.2008.12.002
32. Meigs J. B., Dupuis J., Liu C., O'Donnell C. J., Fox C. S., Kathiresan S., Gabriel S. B., Larson M. G., Yang Q., Herbert A. G., Wilson P. W. F., Feng D., Tofler G. H., Cupples L. A., PAI-1 gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample. Obesity 2006 14 5 753 758 2-s2.0-33846864229 10.1038/oby.2006.85 (Pubitemid 46219713)
33. Brazionis L., Rowley K., Jenkins A., Itsiopoulos C., O'Dea K., Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 4 786 791 2-s2.0-42249114694 10.1161/ATVBAHA.107.160168 (Pubitemid 351651344)
34. Tarnow L., Stehouwer C. D. A., Emeis J. J., Poirier O., Cambien F., Hansen B. V., Parving H. H., Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy. Nephrology Dialysis Transplantation 2000 15 5 625 630 2-s2.0-0034011036 (Pubitemid 30242979)
35. Hallman D. M., Huber J. C., Gonzalez V. H., Klein B. E. K., Klein R., Hanis C. L., Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County, Texas. Diabetes Care 2005 28 5 1163 1168 2-s2.0-18144384717 10.2337/diacare.28.5.1163 (Pubitemid 40616629)
36. Diabetes Control and Complications Trial Research Group, Clustering of long-term complications in families with diabetes in the Diabetes Control and Complications Trial. Diabetes 1997 46 1829 1839
37. Zhang L., Curhan G. C., Hu F. B., Rimm E. B., Forman J. P., Association between passive and active smoking and incident type 2 diabetes in women. Diabetes Care 2011 34 4 892 897 2-s2.0-79956202898 10.2337/dc10-2087
38. Bamashmus M., Gunaid A., Khandekar R., Diabetic retinopathy, visual impairment and ocular status among patients with diabetes mellitus in Yemen: a hospital-based study. Indian Journal of Ophthalmology 2009 57 4 293 298 2-s2.0-68249135142 10.4103/0301-4738.53055
39. Rani P. K., Raman R., Chandrakantan A., Pal S. S., Perumal G. M., Sharma T., Risk factors for diabetic retinopathy in self-reported rural population with diabetes. Journal of Postgraduate Medicine 2009 55 2 92 96 2-s2.0-67651151126 10.4103/0022-3859.48787
40. Chatziralli I. P., Sergentanis T. N., Keryttopoulos P., Vatkalis N., Agorastos A., Papazisis L., Risk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2. BMC Research Notes 2010 3 153 156 2-s2.0-77953764092 10.1186/1756-0500-3-153